An investigation of the visual disturbances experienced by patients on clomiphene citrate

Lyne Racette, Peter R. Casson, Paul Claman, David H. Zackon, Evanne J. Casson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To evaluate the impact of clomiphene citrate on vision. Design: Observational study. Setting: Patients were referred to the University of Ottawa Eye Institute ophthalmology clinic from the Department of Obstetrics and Gynaecology of the Ottawa Hospital-General Campus. Patient(s): Eight adult females taking clomiphene citrate and experiencing visual disturbances. Intervention(s): Patients received a comprehensive visual evaluation twice: once during a washout period, and once during an active clomiphene citrate treatment. Main Outcome Measure(s): Ophthalmologic examination, color vision, visual acuity, contrast sensitivity, visual fields using standard automated perimetry, and foveal flicker sensitivity at high (32 Hz) and low (8 Hz) temporal frequencies. Result(s): We found no differences between the washout and clomiphene citrate conditions for color vision, visual acuity, contrast sensitivity, and visual fields. The only statistically significant difference was found for foveal flicker sensitivity at 32 Hz in the right eye, with a similar trend in the left eye and at 8 Hz in both eyes. Conclusion(s): The effect of clomiphene citrate on vision was minimal, and the visual disturbances were reversible in all patients. A bilateral reduction in flicker sensitivity was the only observed visual disturbance. Women who experience visual symptoms associated with clomiphene citrate should be monitored, but therapy can usually be maintained.

Original languageEnglish (US)
Pages (from-to)1169-1172
Number of pages4
JournalFertility and Sterility
Volume93
Issue number4
DOIs
StatePublished - Mar 1 2010

Fingerprint

Clomiphene
Color Vision
Contrast Sensitivity
Visual Fields
Visual Acuity
Hospital Obstetrics and Gynecology Department
Visual Field Tests
Ophthalmology
Observational Studies
Outcome Assessment (Health Care)
Therapeutics

Keywords

  • Clomid
  • Clomiphene citrate
  • Serophene
  • visual dysfunction
  • visual side effects

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

An investigation of the visual disturbances experienced by patients on clomiphene citrate. / Racette, Lyne; Casson, Peter R.; Claman, Paul; Zackon, David H.; Casson, Evanne J.

In: Fertility and Sterility, Vol. 93, No. 4, 01.03.2010, p. 1169-1172.

Research output: Contribution to journalArticle

Racette, Lyne ; Casson, Peter R. ; Claman, Paul ; Zackon, David H. ; Casson, Evanne J. / An investigation of the visual disturbances experienced by patients on clomiphene citrate. In: Fertility and Sterility. 2010 ; Vol. 93, No. 4. pp. 1169-1172.
@article{e497ae87f62240c997f48dd952eee7b6,
title = "An investigation of the visual disturbances experienced by patients on clomiphene citrate",
abstract = "Objective: To evaluate the impact of clomiphene citrate on vision. Design: Observational study. Setting: Patients were referred to the University of Ottawa Eye Institute ophthalmology clinic from the Department of Obstetrics and Gynaecology of the Ottawa Hospital-General Campus. Patient(s): Eight adult females taking clomiphene citrate and experiencing visual disturbances. Intervention(s): Patients received a comprehensive visual evaluation twice: once during a washout period, and once during an active clomiphene citrate treatment. Main Outcome Measure(s): Ophthalmologic examination, color vision, visual acuity, contrast sensitivity, visual fields using standard automated perimetry, and foveal flicker sensitivity at high (32 Hz) and low (8 Hz) temporal frequencies. Result(s): We found no differences between the washout and clomiphene citrate conditions for color vision, visual acuity, contrast sensitivity, and visual fields. The only statistically significant difference was found for foveal flicker sensitivity at 32 Hz in the right eye, with a similar trend in the left eye and at 8 Hz in both eyes. Conclusion(s): The effect of clomiphene citrate on vision was minimal, and the visual disturbances were reversible in all patients. A bilateral reduction in flicker sensitivity was the only observed visual disturbance. Women who experience visual symptoms associated with clomiphene citrate should be monitored, but therapy can usually be maintained.",
keywords = "Clomid, Clomiphene citrate, Serophene, visual dysfunction, visual side effects",
author = "Lyne Racette and Casson, {Peter R.} and Paul Claman and Zackon, {David H.} and Casson, {Evanne J.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1016/j.fertnstert.2008.11.025",
language = "English (US)",
volume = "93",
pages = "1169--1172",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - An investigation of the visual disturbances experienced by patients on clomiphene citrate

AU - Racette, Lyne

AU - Casson, Peter R.

AU - Claman, Paul

AU - Zackon, David H.

AU - Casson, Evanne J.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Objective: To evaluate the impact of clomiphene citrate on vision. Design: Observational study. Setting: Patients were referred to the University of Ottawa Eye Institute ophthalmology clinic from the Department of Obstetrics and Gynaecology of the Ottawa Hospital-General Campus. Patient(s): Eight adult females taking clomiphene citrate and experiencing visual disturbances. Intervention(s): Patients received a comprehensive visual evaluation twice: once during a washout period, and once during an active clomiphene citrate treatment. Main Outcome Measure(s): Ophthalmologic examination, color vision, visual acuity, contrast sensitivity, visual fields using standard automated perimetry, and foveal flicker sensitivity at high (32 Hz) and low (8 Hz) temporal frequencies. Result(s): We found no differences between the washout and clomiphene citrate conditions for color vision, visual acuity, contrast sensitivity, and visual fields. The only statistically significant difference was found for foveal flicker sensitivity at 32 Hz in the right eye, with a similar trend in the left eye and at 8 Hz in both eyes. Conclusion(s): The effect of clomiphene citrate on vision was minimal, and the visual disturbances were reversible in all patients. A bilateral reduction in flicker sensitivity was the only observed visual disturbance. Women who experience visual symptoms associated with clomiphene citrate should be monitored, but therapy can usually be maintained.

AB - Objective: To evaluate the impact of clomiphene citrate on vision. Design: Observational study. Setting: Patients were referred to the University of Ottawa Eye Institute ophthalmology clinic from the Department of Obstetrics and Gynaecology of the Ottawa Hospital-General Campus. Patient(s): Eight adult females taking clomiphene citrate and experiencing visual disturbances. Intervention(s): Patients received a comprehensive visual evaluation twice: once during a washout period, and once during an active clomiphene citrate treatment. Main Outcome Measure(s): Ophthalmologic examination, color vision, visual acuity, contrast sensitivity, visual fields using standard automated perimetry, and foveal flicker sensitivity at high (32 Hz) and low (8 Hz) temporal frequencies. Result(s): We found no differences between the washout and clomiphene citrate conditions for color vision, visual acuity, contrast sensitivity, and visual fields. The only statistically significant difference was found for foveal flicker sensitivity at 32 Hz in the right eye, with a similar trend in the left eye and at 8 Hz in both eyes. Conclusion(s): The effect of clomiphene citrate on vision was minimal, and the visual disturbances were reversible in all patients. A bilateral reduction in flicker sensitivity was the only observed visual disturbance. Women who experience visual symptoms associated with clomiphene citrate should be monitored, but therapy can usually be maintained.

KW - Clomid

KW - Clomiphene citrate

KW - Serophene

KW - visual dysfunction

KW - visual side effects

UR - http://www.scopus.com/inward/record.url?scp=77249120202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249120202&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2008.11.025

DO - 10.1016/j.fertnstert.2008.11.025

M3 - Article

C2 - 19135656

AN - SCOPUS:77249120202

VL - 93

SP - 1169

EP - 1172

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -